Oral THC Tolerance Persisted Longest on the Gut-Motility Measure in a Mouse Comparison

A 1975 mouse study found different onset and recovery timelines for oral THC tolerance across gut motility, temperature and movement. A single abstinence interval did not describe all three outcomes.

Tolerance developed at different rates

With daily dosing and testing, tolerance to cooling and movement suppression appeared earlier than tolerance to reduced intestinal motility. These were separate physiological and behavioral measurements after oral administration, rather than a composite impairment score.

Recovery also separated the endpoints

The movement effect returned sooner than the cooling response. Partial tolerance to gut-motility suppression was still apparent after a substantially longer dose-free interval. Consequently, return of one THC response could not establish that the animal's entire response profile had returned to its original state.

The pattern challenged one universal mechanism

The authors considered it unlikely that a single explanation such as metabolic tolerance accounted for all results. The comparison supports multiple possible contributors, but the abstract does not establish which molecular mechanism controlled each endpoint. Repeated testing itself was also part of the exposure protocol.

The study supplies a route-specific example of divergent recovery. Its mouse timelines should not be converted into a recommended human tolerance break or a declaration of safety. The endpoint and challenge conditions must be specified when discussing whether tolerance remains.

Related: interpreting cannabis tolerance claims.

Research cited

Anderson PF; Jackson DM; Chesher GB; Malor R. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity. Psychopharmacologia (1975). doi:10.1007/BF00437611. Findings discussed from the study abstract.